PHARMA

1.250

+0.07 (+5.9%)

Change in Boardroom

PHARMANIAGA BERHAD

Date of change 01 Jul 2026
Name ENCIK MOHD FIRDAUS BIN ZULKIFLI
Age 40
Gender Male
Nationality Malaysia
Type of change Redesignation
Previous Position Alternate Director
New Position Director
Directorate Non Independent and Non Executive

Qualifications

No
Qualifications
Major/Field of Study
Institute/University
Additional Information
Masters
Master of Management
Universiti Tun Abdul Razak
Degree
Bachelor of Chemical Engineering
Universiti Putra Malaysia

Working experience and occupation
- August 2025 to Current - Director, Head of Strategic Asset Management at Lembaga Tabung Angkatan Tentera
- March 2023 to August 2025 - Vice President, Corporate Finance at Lembaga Tabung Angkatan Tentera
- November 2021 to February 2023 - Senior Manger, Growth & Strategy at Capital A Berhad (formerly known as Air Asia Group Berhad)
- June 2016 to October 2021 - Head of Business Development, Group Strategy at Naza Corporation Holdings Sdn Bhd
- September 2019 to April 2020 - Interim Head of Company, Naza Communications Sdn Bhd
- July 2014 to May 2016 - Assistant Manager, Corporate Planning at UEM Sunrise Berhad
- January 2013 to June 2014 - Assistant Manager, Managing Director's Office at UEM Edgenta Berhad
- January 2012 to December 2012 - Senior Executive, Operations Control at UEM Edgenta Berhad
- January 2011 to December 2011 - Executive, Corporate Strategy & Business Development at UEM Edgenta Berhad
- June 2009 to December 2010 -  Engineer, Operations & Maintenance at UEM Edgenta Berhad
Family relationship with any director and/or major shareholder of the listed issuer
NIL
Any conflict of interests that he/she has with the listed issuer
Encik Mohd Firdaus bin Zulkifli is the nominee of LTAT.
Details of any interest in the securities of the listed issuer or its subsidiaries
NIL




Announcement Info

Company Name PHARMANIAGA BERHAD
Stock Name PHARMA
Date Announced 30 Jun 2026
Category Change in Boardroom
Reference Number C03-12022026-00005